Msizi Mhlongo | Biology and Life Sciences | Best Researcher Award

Posted on by ScienceFather

Dr. Msizi Mhlongo | Biology and Life Sciences | Best Researcher Award

Senior Lecturer at University of Johannesburg – Department Biochemistry, South Africa

Dr. Msizi Innocent Mhlongo is a distinguished South African biochemist and metabolomics expert, currently serving as Head of the Department of Biochemistry at the University of Johannesburg. With a PhD in Biochemistry and a consistent record of academic excellence, he has authored over 25 peer-reviewed publications and has achieved an impressive Scopus h-index of 16 and Google Scholar h-index of 17. His research spans plant-microbe interactions, LC-MS/GC-MS-based metabolomics, and phytochemical drug discovery, including recent work on COVID-19 therapeutic candidates and microbial communication in the rhizosphere. A mentor to students and a skilled user of advanced analytical tools, Dr. Mhlongo stands out for his contributions to both fundamental and applied biosciences. His growing leadership in academia, dedication to interdisciplinary research, and impactful scientific output position him as a strong contender for prestigious research awards.

Professional Profile 

🎓 Education of Dr. Msizi Innocent Mhlongo

Dr. Msizi Innocent Mhlongo’s academic journey reflects a strong foundation in the life sciences, all earned from the University of Johannesburg. He began with a Bachelor of Science in Botany and Biochemistry in 2012, followed by a BSc Honours in Biochemistry in 2013. Demonstrating academic excellence, he completed his MSc in Biochemistry with distinction in 2015. His pursuit of advanced scientific inquiry culminated in a PhD in Biochemistry, awarded in May 2020. Further highlighting his commitment to leadership in academia, Dr. Mhlongo also completed an Emerging Leader Development Programme with distinction in December 2022. His educational path showcases a blend of scientific rigor and leadership preparation.

💼 Professional Experience of Dr. Msizi Innocent Mhlongo

Dr. Msizi Innocent Mhlongo has built a dynamic and progressive career in academia and research, primarily at the University of Johannesburg. He currently holds the position of Head of the Department of Biochemistry (as of August 2025) and serves as a Senior Lecturer since January 2022. His earlier roles include Lecturer (2020–2022), Assistant Lecturer (2018–2020), and Research Assistant (2018), showcasing a steady academic ascent. He also gained research experience as a Junior Researcher at the University of the Free State in 2015 and served as a Student Practical Demonstrator from 2013 to 2017. Throughout his career, Dr. Mhlongo has contributed to research, student mentorship, and departmental leadership, establishing himself as a committed educator and an influential researcher in biochemistry and metabolomics.

🔬 Research Interests of Dr. Msizi Innocent Mhlongo

Dr. Msizi Innocent Mhlongo’s research interests lie at the intersection of biochemistry, metabolomics, plant–microbe interactions, and phytochemical drug discovery. He specializes in using liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) to profile complex biological systems, particularly focusing on plant growth-promoting rhizobacteria (PGPR), microbial signaling, and the biochemical mechanisms underlying plant defense. His work also extends to network pharmacology and molecular docking, identifying therapeutic potential in natural compounds—especially against diseases such as COVID-19 and malaria. Through integrative omics approaches and computational biology tools, Dr. Mhlongo aims to decode the chemical language of plant-microbe interactions and translate bioactive metabolite research into pharmaceutical and agricultural innovations.

🏆 Awards and Honors of Dr. Msizi Innocent Mhlongo

Dr. Msizi Innocent Mhlongo has been recognized for both his academic excellence and leadership potential. A notable achievement includes earning distinction in the prestigious Emerging Leader Development Programme at the University of Johannesburg in December 2022, underscoring his dedication to personal and professional growth in academic leadership. While his early career is still unfolding, his growing citation metrics, senior academic roles, and impactful research publications signal a trajectory marked by scholarly recognition. These accomplishments position him as a rising figure in biochemical and metabolomics research, with strong potential for future national and international honors.

🏁 Conclusion

Dr. Msizi Innocent Mhlongo is highly suitable for the Best Researcher Award based on his scientific productivity, methodological expertise, leadership, and thematic relevance. His scholarly journey shows depth in metabolomics and plant–microbe biochemistry, contributing valuable insights, especially in PGPR (plant growth-promoting rhizobacteria), medicinal plants, and antimicrobial research.

Publications Top Noted📚

  1.  Title: Exploring the intricacies of plant growth promoting rhizobacteria interactions: an omics review
     Authors: Mmotla, K., Sibanyoni, N. R., Allie, F., Sitole, L., Mafuna, T., Mashabela, M. D., Mhlongo, M. I.
     Journal: Annals of Microbiology
     Year: 2025
     Citations: 4

        2. Title: Molecular docking and network pharmacology highlight salvianolic acids as potential inhibitors and therapeutic agents for COVID-19 treatment
            Authors: Msobo, A., Mashabela, M. D., Koorsen, G., Tsotetsi, T. N., Piater, L. A., Madala, N. E., Tshiwawa, T., Mhlongo, M. I.
            Journal: Phytochemistry Letters
           Year: 2025
           Citations: 0

Bechan Sharm | Biology and Life Sciences | Outstanding Scientist Award

Posted on by ScienceFather

Bechan Sharm | Biology and Life Sciences | Outstanding Scientist Award

Professor of Biochemistry, University of Allahabad, India

Prof. Dr. Bechan Sharma is a distinguished Indian biochemist with a career spanning over three decades. Currently a Professor at the University of Allahabad, he is renowned for his work in molecular biology, virology, biochemical toxicology, and nanobiotechnology. With a Ph.D. in Biochemistry from Banaras Hindu University and CDRI-Lucknow, his research has contributed significantly to the understanding of tropical diseases, free radical biology, and drug discovery. He is recognized globally for his impactful publications, international collaborations, and advisory roles. A passionate educator and mentor, Prof. Sharma has guided numerous students and scientists. His commitment to science is also reflected in his leadership roles, including Head of Department and Dean positions. Ranked among the world’s top 2% scientists by Stanford University, he remains at the forefront of interdisciplinary biomedical research, promoting innovative science and academic excellence both in India and globally.

Publication Profile

Google Scholar

Education

Prof. Dr. Bechan Sharma is a distinguished Indian biochemist and academician with over three decades of impactful contributions in molecular biology, virology, biochemical toxicology, and drug development. He currently serves as a Professor at the University of Allahabad, India, and has held various academic and administrative roles, including Head of Department and Dean. A prolific researcher, Prof. Sharma is ranked among the world’s top 2% scientists by Stanford University for multiple consecutive years. His work spans diverse areas such as tropical diseases, phytomedicine, nanobiotechnology, and environmental toxicology. With over 200 research publications and active involvement in global scientific committees, Prof. Sharma has significantly advanced our understanding of free radical biology and the therapeutic potential of natural compounds. He is also known for mentoring young researchers and fostering interdisciplinary collaboration. His scholarly excellence and dedication to societal health make him an ideal candidate for the Outstanding Scientist Award.

Experience

Prof. Dr. Bechan Sharma’s academic journey reflects excellence from the start. He completed his High School and Intermediate education from the U.P. Board with First Division, receiving distinctions in core science subjects. He earned a B.Sc. (Hons.) in Botany, Zoology, and Chemistry (1980), followed by an M.Sc. in Biochemistry (1982), both from the prestigious Banaras Hindu University (BHU), Varanasi. He then pursued his Ph.D. in Biochemistry from BHU and CDRI-Lucknow, awarded in 1988. His doctoral research focused on the purification and characterization of key enzymes from the filarial parasite Setaria cervi, laying the foundation for his work in tropical disease research. Over the years, he enhanced his expertise through international training and certifications in chemical safety, biohazards, radiation safety, and bioinformatics from institutions in the USA, India, and The Netherlands. His academic foundation is strongly multidisciplinary, blending classical biochemistry with cutting-edge molecular and environmental sciences. 📘🧪

Awards & Honors

Prof. Sharma has received numerous prestigious accolades. Notably, he was ranked among the top 2% of scientists globally by Stanford University in 2022, 2023, and 2024. In 2024, he received the Global Health Award by the Volkswagen Foundation in Germany. His national recognitions include the Excellence in Academics and Research Award (2023, University of Allahabad) and Paryavaran Ratan Award (2022) by ABRF. In 2023, he was honored with the Birendra Singh Memorial Glocal Award for social service. His international exposure includes scholarships from Virology Education, The Netherlands, for attending major workshops on HIV and aging. His leadership roles include serving as a keynote speaker, chairman, and organizing committee member for international scientific summits across Italy, Japan, Belgium, and the UK. Prof. Sharma’s awards reflect not only scientific excellence but also his impact on public health, education, and environmental sustainability. 🥇🌿

Research Focus

Prof. Sharma’s multidisciplinary research spans molecular biology, virology, biochemical toxicology, phytomedicine, free radical biology, and nanobiotechnology. His early work on filarial parasite enzymes led to impactful insights into tropical disease mechanisms. He has contributed to drug development research for metabolic disorders, neurodegeneration, and infectious diseases, including HIV. His studies on phytochemicals, probiotics, and herbal medicine reflect a deep interest in sustainable therapeutics. Prof. Sharma has also made significant strides in green nanotechnology, notably in silver and gold nanoparticle synthesis using plant extracts for biomedical applications. He integrates traditional Indian medicinal knowledge with modern science to address pressing health issues such as diabetes, liver toxicity, and heavy metal contamination. His commitment to translational research, combining lab findings with public health outcomes, makes him a global thought leader in biochemistry and allied fields. ⚗️🌿🧬

Publication Top Notes

Parthenium leaf extract mediated synthesis of silver nanoparticles: a novel approach towards weed utilization.

Water pollution with special reference to pesticide contamination in India

Analysis of some heavy metals in the riverine water, sediments and fish from river Ganges at Allahabad

Inhibitory activity of Indian spice plant Cinnamomum zeylanicum extracts against Alternaria solani and Curvularia lunata, the pathogenic dematiaceous moulds

Toxicological effects of berberine and sanguinarine

Biochemical and molecular bases of lead-induced toxicity in mammalian systems and possible mitigations

Flower-based green synthesis of metallic nanoparticles: Applications beyond fragrance

Green Biosynthesis of Silver Nanoparticles Using Leaf Extract of Carissa carandas L. and Their Antioxidant and Antimicrobial Activity against Human Pathogenic …

 

 

Gang LIU | Drug Discovery | Best Researcher Award

Posted on by ScienceFather

Gang LIU | Drug Discovery | Best Researcher Award

Prof Gang LIU, Tsinghua University, China

Prof. Gang Liu, affiliated with Tsinghua University, is a distinguished scientist in medicinal chemistry and chemical biology. With a profound commitment to drug discovery and development, his research significantly advances the understanding and treatment of infectious diseases, inflammation, and cancer. Prof. Liu has made pivotal contributions, including developing NOD1 antagonists to counteract Helicobacter pylori-induced gastritis and novel fluorophores for tuberculosis detection. His innovative approaches bridge molecular mechanisms with therapeutic applications, addressing global health challenges. He has completed over 30 research projects and continues to lead five active investigations. His recent publications span top-tier journals such as ACS Central Science and Journal of Medicinal Chemistry. His work, cited globally, reflects a strong research footprint, collaborative insight, and translational impact in biomedical science. Prof. Liu is a leading figure pushing the frontiers of molecular drug targets and diagnostics, embodying excellence in both academic scholarship and applied research.

Publication Profile

orcid

Education

While exact degrees are not specified in the provided data, Prof. Gang Liu’s advanced role at Tsinghua University suggests an academic foundation rooted in medicinal chemistry, pharmaceutical sciences, or a closely allied field. Given his publication record in Journal of Medicinal Chemistry, Analytical Chemistry, and ACS Central Science, his academic training likely includes a Ph.D. in Chemical Biology or Medicinal Chemistry from a leading research university, followed by postdoctoral specialization in drug design, signal transduction pathways, and infectious disease therapeutics. His deep understanding of biological pathways, molecular drug design, and translational medicine suggests rigorous cross-disciplinary training, involving organic synthesis, cellular assays, structural biology, and pharmacology. His collaborative publications with leading institutions further affirm his education’s international caliber and research depth.

Experience

Prof. Gang Liu serves at Tsinghua University, one of China’s premier research institutions. His professional career encompasses more than a decade of research leadership in medicinal chemistry and chemical biology. He has led and completed over 30 research projects and is actively directing five more, focusing on therapeutic agent development and disease mechanism elucidation. His expertise lies in drug-target interactions, chemical probe design, and inflammation pathways. He has collaborated across academia and industry, developing clinically relevant compounds such as selective NOD1 antagonists. Prof. Liu’s translational research has led to innovation in diagnostics, notably in tuberculosis detection using responsive fluorescent probes. His experience spans mentoring Ph.D. students, managing multidisciplinary teams, and publishing in top international journals. Prof. Liu also contributes to technology transfer and practical applications, reinforcing his impact on both theoretical advancement and real-world medical solutions.

Awards and Honors

Although no specific awards are listed, Prof. Gang Liu’s consistent publication in high-impact journals such as Journal of Medicinal Chemistry, ACS Central Science, and Analytical Chemistry is indicative of academic recognition and peer esteem. His groundbreaking development of a selective NOD1 antagonist for H. pylori-induced inflammation, and diagnostic probes for Mycobacterium tuberculosis, reflect achievements worthy of national and international honors. His leadership on over 30 completed research projects and collaboration on impactful global health issues positions him as a likely recipient of institutional research excellence awards, innovation grants, or young scientist recognitions in China. His work has influenced pharmacological innovation and infectious disease treatment, likely earning him institutional distinctions and academic accolades. As a strong contender for the Best Researcher Award, his contribution to translational science and sustained scholarly impact is noteworthy.

Research Focus

Prof. Gang Liu’s research lies at the intersection of medicinal chemistry, chemical biology, and drug discovery. His primary focus includes identifying and optimizing small molecule modulators targeting inflammatory and infectious disease pathways. Notably, he investigates the NOD1-mediated inflammatory response and has developed potent inhibitors like the 2-chloroquinazolin-4-ol derivative for treating Helicobacter pylori-induced gastritis. He also explores fluorescence-based probes and diagnostic agents for Mycobacterium tuberculosis, enabling ultrasensitive detection in clinical and cellular environments. Prof. Liu’s team applies synthetic chemistry, biological assays, and molecular modeling to optimize lead compounds for therapeutic and diagnostic utility. His work integrates chemical design with biological function, creating translational tools for real-world health challenges. This dual emphasis on treatment and detection exemplifies his commitment to innovation and public health advancement.

Publication Top Notes

Insights into IrtAB: Iron Transport Facilitates Ultrasensitive Detection of Mycobacteria in Both Cellular and Clinical Environments

Selectively Antagonizing the NOD1-Mediated Inflammatory Signaling Pathway Mitigates the Gastric Inflammation Induced by Helicobacter pylori Infection

Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives

From Bench to Clinic: A Nitroreductase Rv3368c-Responsive Cyanine-Based Probe for the Specific Detection of Live Mycobacterium tuberculosis

Optimization of nitrofuranyl calanolides for the fluorescent detection of Mycobacterium tuberculosis

Identification of 1,4-Benzodiazepine-2,5-dione Derivatives as Potential Protein Synthesis Inhibitors with Highly Potent Anticancer Activity

Extracellular vesicles from colorectal cancer cells promote metastasis via the NOD1 signalling pathway 

Khurshid Ahmad | Biotechnology | Best Researcher Award

Posted on by ScienceFather

Khurshid Ahmad | Biotechnology | Best Researcher Award

Mr Khurshid Ahmad, Ocean University of China, China

Mr. Khurshid Ahmad is an emerging scholar in the field of Food Science and Biotechnology, currently completing his PhD (2020–2025) at Ocean University of China. With a solid academic foundation in Biotechnology and Genetic Engineering, his research spans nanotechnology applications, marine biomaterials, enzyme utilization in industry, and food safety. He has authored over 25 peer-reviewed research articles and co-authored notable book chapters. Mr. Ahmad brings both academic excellence and practical industry experience, having served as a Visiting Lecturer, Research Assistant, and Quality Manager in various reputable institutions. A regular speaker at international conferences and seminars, he has also contributed significantly to academic exchange programs. His interdisciplinary approach and dedication to research innovation underscore his eligibility for the Best Researcher Award. With impactful collaborations and a growing citation footprint, he stands out as a young scientist poised to contribute significantly to global food and biotechnology challenges.

Publication Profile

Google Scholar

Education

Mr. Khurshid Ahmad has a well-rounded and progressive academic background. He is currently pursuing his Ph.D. (2020–2025) in Food Science and Engineering from the Ocean University of China (OUC), where he focuses on novel bio-composite materials and nanotechnology in food applications. He completed his M.Phil. (2017–2019) in Biotechnology from International Islamic University, Islamabad (IIUI), Pakistan, and his Bachelor’s (BS Hons, 2012–2016) in Biotechnology and Genetic Engineering from Kohat University of Science & Technology (KUST), Pakistan. His foundational education includes Pre-Medical studies (HSSC, 2010–2012) under the Board of Intermediate and Secondary Education, Kohat. Throughout his academic career, Mr. Ahmad has consistently demonstrated research aptitude and excellence, laying a strong educational platform for his multidisciplinary research in the food and life sciences sectors.

Experience

Mr. Ahmad has over 8 years of progressive research and teaching experience. As a Visiting Lecturer at IIUI (2020–2022), he taught Biological Sciences while mentoring students in applied research. His role as Quality Manager at Margallah Food and Beverages Industry (2019–2020) provided critical insight into food safety and quality control protocols. During his Graduate Research Assistantship (2017–2018) at IIUI, he worked on nanowires’ impact on α-amylase production. He also served as Research Assistant at KUST, studying the remediation of heavy metal-contaminated areas, and conducted undergraduate research on probiotic Lactobacilli from poultry intestines. These varied roles have refined his skills in microbiology, enzymology, food safety, and nanobiotechnology. His blend of industry and academic experience uniquely equips him to contribute to both applied and theoretical aspects of biosciences.

Awards and Honors

Mr. Ahmad has been actively recognized for his academic and research contributions. He was a speaker at the 2024 “Embracing Blue Doctor Academic Seminar” at OUC, China. His academic excellence has been acknowledged through degree equivalence and instruction certifications by KUST in 2016. He has participated in multiple national workshops and seminars, such as “Molecular Cloning to Drug Development” (IIUI, 2018), and “Food Safety & Security” (IIUI, 2017). He served as an organizer of the KUST Annual Gathering and participated in awareness seminars on malaria and honeybee products. His early exposure to research at the undergraduate level and continued participation in capacity-building seminars showcases his long-term dedication to academic development and public health. These engagements underline his commitment to bridging research with societal impact, strengthening his candidacy for the Best Researcher Award.

Research Focus

Mr. Ahmad’s research focuses on Food Science, Nanobiotechnology, Enzymatic Processing, and Marine Biomaterials. His current PhD work involves the development and characterization of marine collagen-based bio-composites and their functional applications in food safety and drug delivery. He is particularly interested in nano-enabled materials in food packaging and preservation. His past research has explored mycotoxin detection, α-amylase optimization using nanowires, and bioremediation of heavy metals. He also investigates the role of retinoic acid in regeneration, merging biotechnology with regenerative medicine. His interdisciplinary approach links sustainability, health, and innovation, as reflected in his book chapters on enzymes in textile and sustainable industry practices. By addressing food safety and bioactive compounds, his research contributes to both global food security and environmental safety, aligning with the UN Sustainable Development Goals (SDGs).

Publication Top Notes

Quality deterioration of postharvest fruits and vegetables in developing country Pakistan: A mini overview

Organic waste-to-bioplastics: Conversion with eco-friendly technologies and approaches for sustainable environment

Chitosan interaction with stomach mucin layer to enhances gastric retention and mucoadhesive properties

Nanotechnology in food packaging with implications for sustainable outlook and safety concerns

Alkaline lipase production by novel meso-tolerant psychrophilic Exiguobacterium sp. strain (AMBL-20) isolated from glacier of northeastern Pakistan

Advancements in sustainable production of biofuel by Microalgae: Recent insights and future directions

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Posted on by ScienceFather

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

 

 

 

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Posted on by ScienceFather

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Dr Mar Villamiel, CIAL, CSIC-UAM, Spain

Dr. Mar Villamiel is the Director of CIAL (Institute of Food Science Research, CSIC-UAM) in Spain and leads the PREBIOIN research group focused on carbohydrate functionality and food bioactivity. With a PhD in Pharmacy from Complutense University of Madrid, she specializes in food technology, bioactive carbohydrates, and sustainable food preservation. Her innovative research centers on extracting and characterizing pectin and other functional ingredients from agri-food by-products. Dr. Villamiel has coordinated over 70 research projects and contracts, published 173 JCR articles (h-index: 46 WoS), co-authored 20 book chapters, and holds 7 patents. Her work has earned her national and international recognition, including being named among the Top 2% of Scientists worldwide by Stanford University. Passionate about science communication, she has presented at over 150 conferences and supervised more than 50 academic theses and internships globally. Her commitment to sustainability and technological advancement defines her as a leading force in food science research.

Publication Profile

Orcid

Education

Dr. Mar Villamiel completed her undergraduate degree in Pharmacy at Complutense University of Madrid in 1991 and earned her PhD in Pharmacy from the same institution in 1995. Her doctoral studies laid the groundwork for a highly interdisciplinary research career, incorporating analytical chemistry, food technology, and functional foods. Postdoctoral work in the Netherlands and professional exchanges in the UK expanded her knowledge in sustainable food preservation and the development of bioactive food compounds. Her deep educational foundation has supported her leadership in developing advanced methodologies in food science. Through ongoing academic collaborations and international stays, she continues to enhance her expertise and contribute to global education, mentoring students and researchers across Europe, Latin America, and beyond. Her academic path reflects a consistent trajectory of excellence, innovation, and dedication to research in food bioactivity and sustainable processing technologies. 🎓🔍📘🌍

Experience

Dr. Villamiel has over two decades of experience in food science research, beginning her career as a Tenured Scientist at CSIC (2000–2009). She later served as Deputy Director (2017–2019) and is currently the Director of CIAL since March 2021. She leads the PREBIOIN group, which explores carbohydrate functionality, pectin extraction, and sustainable food technologies. She has led 8 international projects, 34 industry contracts, and 72 total projects, often as Principal Investigator. She has published widely, mentored numerous PhDs (including international awardees), and edited prestigious scientific journals. Her collaborations span across institutions in Europe, Latin America, and Asia. She actively participates in EU regulatory panels and scientific committees and has received 10 research awards. Her interdisciplinary approach and leadership have made significant impacts in agri-food revalorization, food preservation, and nutritional functionality.

Awards and Honors

Dr. Mar Villamiel’s outstanding contributions have earned her numerous accolades, including 10 research awards and inclusion in the Stanford–Elsevier World’s Top 2% Scientists list in 2024. She has received five positive evaluations for six-year research periods, attesting to the sustained quality and impact of her work. Her research achievements include 7 patents (2 international), 173 JCR-indexed publications, and leadership of multi-million-euro research projects. She has served as an editor for major scientific journals and been an invited speaker at 17 international conferences. Her innovative methodologies in pectin extraction and bioactive compound analysis have been recognized with top conference awards, including First Prize at the Food Chemistry Conference (2023). She represents CSIC on platforms like the Biobased Industries Consortium and Food for Life. Her awards reflect her global influence, scientific leadership, and unwavering commitment to advancing sustainable food research.

Research Focus

Dr. Villamiel’s research focuses on the chemistry and functionality of carbohydrates, particularly pectins derived from agri-food by-products. She pioneers green extraction technologies such as ultrasound and subcritical water methods to obtain high-value bioactive compounds. Her work contributes significantly to sustainable food systems, enabling revalorization of food waste and enhancing nutritional profiles of food products. She leads multiple international collaborations and has developed in vitro digestion models to study carbohydrate behavior in the human gut. Her research addresses pressing challenges in food preservation, functional ingredient development, and biorefinery approaches for the food industry. With 173 publications, a high h-index (47 Scopus), and leadership in EU and Latin American projects, she is at the forefront of innovation in food science. Her contributions support public health, environmental sustainability, and industrial competitiveness through novel bioactive food solutions.

Publication Top Notes

Flours from popped grains: Physicochemical, thermal, rheological, and techno-functional properties

Use of natural low‐methoxyl pectin from sunflower by‐products for the formulation of low‐sucrose strawberry jams

Integral use of pectin-rich by-products in a biorefinery context: A holistic approach

Apple pomaces derived from mono-varietal Asturian ciders production are potential source of pectins with appealing functional properties

Application of sunflower pectin gels with low glycemic index in the coating of fresh strawberries stored in modified atmospheres

Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Posted on by ScienceFather

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Prof Lina Vieira, ESTeSL/IPL, Portugal

Prof. Lina Vieira is a distinguished biomedical researcher and educator with a PhD in Biomedical Engineering and Biophysics from the University of Lisbon 🎓, awarded with Distinction and Honors 🏅. Her work primarily advances nuclear medicine, with a special focus on myocardial perfusion scintigraphy and SPECT imaging 🧠❤️. She holds a professorial position at the Lisbon School of Health Technology, actively contributing to both teaching and scientific innovation 📚🔬. Prof. Vieira has led several EU-funded projects, including PIANOFORTE, focusing on safe, optimized radiology for vulnerable populations 🤰📡. Her research blends technology, biophysics, and human-centered approaches like anxiety reduction and music therapy in imaging 🧘‍♀️🎵. An award-winning author and supervisor, she has trained numerous graduate students and remains a leading voice in radiological safety and optimization ⚛️. Her scientific rigor, innovation, and societal impact make her an ideal candidate for the Research Hypothesis Excellence Award 🏆🔍.

Publication Profile

Orcid

Education

Prof. Lina Vieira earned her PhD in Biomedical Engineering and Biophysics from the University of Lisbon in 2011 with Distinction and Honors 🎓🌟. Her thesis focused on optimizing myocardial perfusion studies using ECG-gated nuclear medicine imaging ❤️🧠. She also holds a Postgraduate Degree in Medical Physics and Biomedical Engineering (2005) and a Bachelor’s in Nuclear Medicine (2000) from the Lisbon School of Health Technology ⚛️📘. As part of her academic growth, she qualified through rigorous public examinations to become a Coordinating Professor in Nuclear Medicine within the Radiation Sciences and Biosignal Technologies Department at ESTeSL 👩‍🏫🧪. Her scholarly training is grounded in biophysics, imaging technology, and healthcare applications, forming a strong foundation for her future academic, research, and leadership achievements 🔬💡.

Experience

Prof. Vieira serves as a Coordinating Professor at the Lisbon School of Health Technology, leading Nuclear Medicine teaching and research initiatives 👩‍🏫🧠. She has been an integrated member of the Health & Technology Research Center since 2019, previously with the Institute of Biophysics and Biomedical Engineering at the University of Lisbon 🧬📊. Her work spans across modeling, signal processing, and human-centered diagnostic imaging, including participation in CIMOSM and GI-MOSM research centers 🧠⚙️. Notably, she coordinates the EU-funded PIANOFORTE project on safe radiology for pregnant patients 🤰📡, and leads innovative research on anxiety and music’s impact on image quality 🎵😌. Prof. Vieira is a mentor to many MSc students and has supervised several dissertations on SPECT imaging, Parkinson’s diagnostics, and PET education 📚📝. Her cross-disciplinary expertise makes her a leader in merging clinical practice with scientific excellence 🏥🔍.

Awards and Honors

Prof. Vieira has received multiple prestigious awards honoring her innovative research in nuclear medicine and imaging technology 🏅📡. She earned the Best Scientific Article Award from Saúde & Tecnologia in 2018, 2017, and 2015 for studies on technologist exposure, myocardial perfusion, and PET/CT in melanoma surveillance 🎖️📘. Her paper, “Value of a Lower Limb Immobilization Device for Optimization of SPECT/CT Image Fusion,” was named one of the Top 3 Papers by JNMT in 2015 and recognized at the 2016 Annual SNMMI Congress in San Diego 🇺🇸✨. These accolades reflect her commitment to high-impact, hypothesis-driven research that enhances clinical outcomes and patient safety 🧠❤️. With consistent recognition over the years, Prof. Vieira continues to lead innovations in nuclear medicine, both theoretically and practically 🔬📈.

Research Focus

Prof. Vieira’s research centers on optimizing nuclear medicine imaging, particularly myocardial perfusion scintigraphy (MPS), SPECT acquisition techniques, and patient-centered innovations in diagnostic imaging ❤️📸. She investigates the impact of psychophysiological variables, such as anxiety, on image quality and explores non-pharmacological interventions like music therapy to improve patient outcomes 🎶🧘‍♂️. A strong advocate for radiological safety, she spearheads projects like PIANOFORTE, which targets personalized radiology for pregnant patients 🤰⚛️. She also delves into educational methodologies, evaluating the effect of videos and social media in communicating ionizing radiation risks effectively 📲🧠. Her interdisciplinary focus combines engineering, patient psychology, radiological science, and public communication—making her work vital for improving both technical precision and patient experience in medical imaging 💡🩺. Her hypothesis-driven approach is rooted in measurable impacts, clinical relevance, and ethical responsibility 🔍📐.

Publication Top Notes

  • 📄 Myocardial Perfusion Scintigraphy: Impact of Anxiety on Image Quality (JPM, 2025 – submitted)

  • 📄 Potential Benefits of Social Media in Educating Healthcare Professionals and Students on Medical Imaging with Ionizing Radiation (Radiography Journal, 2025)

  • 📄 Effects of a Music-Based Intervention on Psychophysiological Outcomes of Patients Undergoing Imaging Procedures: A Systematic Review (Radiography Journal, 2024)

  • 📄 Effectiveness of Educational Videos on Patient’s Preparation for Diagnostic Procedures: Systematic Review and Meta-Analysis (Preventive Medicine Reports, 2022)

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Posted on by ScienceFather

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. 🐖📈 Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. 🇳🇴🔬 He also serves part-time as a church servant at Uranienborg Menighet since 2020. ⛪ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). 🛡️🏥 With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. 🎓🌍 His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. 🦠📖 A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. 🏆✨

Publication  Profile

Orcid

Education 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. 🎓🐾 He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. 🇳🇴📚 He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. 🇺🇸📊 Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. 🇦🇺🩺 His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. 🏅🌟

Experience 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. 🐷📊 In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. ⛪ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. 🐔🔍 He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). 🎖️🚛 These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. 🏅📈

Awards and Honors 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. 🐾📈 His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. 🦠🔬 His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. 🇳🇴🐖 Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. 🎖️🌏 Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. 🏅📚 His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research Focus 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. 🐖🦠 His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. 📊🛡️ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. 📈🖥️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. 🧬🔍 Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. 📑📈 His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. 🏆🔬 His work supports healthier livestock systems and contributes to global food security. 🌍🍖

Publications Top Notes

  • 📄 “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • 📄 “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • 📄 “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • 📄 “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • 📄 “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • 📄 “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

Sheeja Sheela Rajan | Biology and Life Sciences | Best Researcher Award

Posted on by ScienceFather

Sheeja Sheela Rajan | Biology and Life Sciences | Best Researcher Award

Dr Sheeja Sheela Rajan, University of Johannesburg, South Africa

Dr. Sheeja Sheela Rajan is a distinguished biochemist with extensive experience in venom pharmacology, molecular biology, and neurobehavioral research. She earned her Ph.D. in Biochemistry from Manonmaniam Sundaranar University, where her thesis on Bungarus caeruleus venom received high acclaim. Currently, she serves as a Postdoctoral Fellow at the Laser Research Centre, University of Johannesburg. Her research spans enzyme purification, coagulation mechanisms, clock gene regulation, and stress neurobiology using Drosophila melanogaster as a model. Dr. Rajan has held academic leadership roles and has taught biochemistry across reputed institutions in India. She is a prolific author, with several peer-reviewed publications in international journals. Passionate about bridging traditional biochemistry with modern biomedical science, she continues to contribute to global health and toxicology. Her achievements and dedication to research excellence make her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Dr. Sheeja Sheela Rajan completed her Ph.D. in Biochemistry (2010–2015) from Manonmaniam Sundaranar University, Tamil Nadu, India. Her doctoral work focused on the “Pharmacological characterization and purification of dominant enzymes from Bungarus caeruleus venom for coagulation and hemotoxic studies,” earning her high praise and official award in September 2015. She holds an M.Sc. in Biochemistry (2007–2009) from Malankara College, Tamil Nadu, where she investigated “DAZ-1 expression in azoospermic males.” Her strong academic foundation blends molecular biology, enzymology, and toxicology, laying the groundwork for a career in both research and academia. Her interdisciplinary education reflects her ability to integrate classical biochemistry techniques with innovative approaches in behavioral and venom-based biomedical research.

Experience

Dr. Rajan is currently a Postdoctoral Fellow at the Laser Research Centre, Faculty of Health Science, University of Johannesburg (2023–present), exploring stress response and neurobehavior in Drosophila. She previously served as a Postdoctoral Fellow at Annamalai University (2018–2021), researching venom pharmacology and biochemical mechanisms. Her academic career includes roles as Assistant Professor and Head of the Department at Excel College for Commerce and Science (2022–2023) and Dean of Student Affairs at Thievanai Ammal College for Women (2015–2018). Her research journey began as a Research Scholar at Manonmaniam Sundaranar University (2010–2015) and Malankara Catholic College (2007–2009). Dr. Rajan combines academic leadership with experimental expertise in toxicology, molecular biology, and behavioral science.

Awards and Honors

Dr. Rajan was awarded a Postdoctoral Fellowship at Annamalai University (2018–2021) in recognition of her advanced research in biochemistry and venom pharmacology. Her Ph.D. thesis received high commendation for its innovative exploration of hemotoxic enzymes in Bungarus caeruleus venom. She has presented her work at prestigious international and national conferences, including those on biodiversity, chronobiology, and optics. A respected member of the Indian Society for Biological Chemists and the Indian Biochemical Society, she actively contributes to academic discussions and interdisciplinary collaboration. Dr. Rajan’s excellence in teaching and research has earned her recognition in multiple roles, including department head and dean, highlighting her dedication to student mentorship and scientific innovation.

Research Focus

Dr. Sheeja Sheela Rajan’s research bridges venom pharmacology, molecular biology, and neurobehavioral science. Her doctoral research explored the purification and characterization of venom enzymes from Bungarus caeruleus, focusing on their effects on coagulation and hemotoxic pathways. Her postdoctoral work investigates clock genes, stress regulation, and circadian rhythm modulation using Drosophila melanogaster. She studies how food deprivation influences sleep, memory, and sensory responses in fruit flies, using venom components and phenolic compounds to track behavioral and anti-stress responses. Her interest in biochemical pathways conserved between humans and flies positions her research at the forefront of translational studies. With a robust background in toxicology, PCR, cell culture, fluorescence microscopy, and animal models, she contributes significantly to both fundamental and applied biomedical sciences.

Publication Top Notes

Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis

Advancing Photodynamic Therapy with Nano-Conjugated Hypocrellin: Mechanisms and Clinical Applications

Overcoming challenges in cancer treatment: Nano‐enabled photodynamic therapy as a viable solution

SNAKE VENOM-DERIVED PEPTIDES AS PROSPECTIVE PHARMACOLOGICAL TOOLS: RECENT TRENDS

Biological clock and carcinogenesis: role of <i>Lobophora variegata</i> extract on liver cancer

Multidrug Resistance for Cancer Treatment: Delivery of Ursolic Acid and Caffeine by Poly (Lactic-Co-Glycolic Acid) Nanoparticles

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis